Virtual Bioequivalence: an update from PAGE (+TSD!) [Dissolution / BCS / IVIVC]

posted by mittyri – Russia, 2019-06-21 13:50 (463 d 03:39 ago) – Posting: # 20356
Views: 2,111

Dear All!

here's the update from the latest PAGE meeting:
  1. Model-based approach for group sequential and adaptive designs in parallel and cross-over bioequivalence studies
    AFAIK this one is the most interesting. Authors are INSERM and FDA people. But it looks like their adaptive design cannot control TIE. How come?
  2. Selection of optimal study design based on the bioequivalence simulation study in highly variable drugs
  3. An In Vitro – In Vivo Simulation Methodology for Predicting the Outcome of Bioequivalence Studies
  4. Investigation of the impact of population parameters describing gastric emptying on bioequivalence metrics

Kind regards,
Mittyri

Complete thread:

Activity
 Admin contact
21,076 posts in 4,394 threads, 1,469 registered users;
online 6 (2 registered, 4 guests [including 2 identified bots]).
Forum time: Saturday 17:30 CEST (Europe/Vienna)

For every fact
there is an infinity of hypotheses.    Robert M. Pirsig

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5